Effects of common variations of NOS3 and CAV1 genes on hypercholesterolemic profile in coronary heart disease

These results suggested that the genetic variations of CAV-1 rs3807990 and NOS3-rs1799983 may contribute to the increased hypercholesterolemia risk and thus on the development of CHD.Cite this article as: İlikay S, Coşkunpınar E, Kurnaz-Gömleksiz Ö, Buğra Z, Eronat AP, Öztürk O, Yılmaz-Aydoğan H (2019).

📌 3 Key Takeaways

🎯

Objective & Hypothesis:DOI: 10.26650/IstanbulJPharm.2019.18010Caveolin-1 (CAV-1) plays a crucial role in endothelial-nitric oxide synthase (eNOS) enzymatic activity.

📊

Key Findings & Data:Therefore, CAV-1 and eNOS interactions have a significant impact on endothelial dysfunction, cholesterol levels, and atherosclerosis.

💡

Conclusion & Impact:These results suggested that the genetic variations of CAV-1 rs3807990 and NOS3-rs1799983 may contribute to the increased hypercholesterolemia risk and thus on the development of CHD.Cite this article as: İlikay S, Coşkunpınar E, Kurnaz-Gömleksiz Ö, Buğra Z, Eronat AP, Öztürk O, Yılmaz-Aydoğan H (2019).

🔬Design:Research Article

📍Scope:2019 Verileri

⚙️Variables:Cav1 · NOS3 · gene

Abstract

DOI: 10.26650/IstanbulJPharm.2019.18010Caveolin-1 (CAV-1) plays a crucial role in endothelial-nitric oxide synthase (eNOS) enzymatic activity. Therefore, CAV-1 and eNOS interactions have a significant impact on endothelial dysfunction, cholesterol levels, and atherosclerosis. We investigated the critical variations in NOS3 and CAV1 genes in this case–control study to determine the relations between the coronary heart disease (CHD) risk factors. The NOS3-rs1799983, CAV-1 rs3840634, and rs3807990 variations were analyzed in 76 CHD patients and 91 controls using the polymerase chain reaction. Mean serum Total-cholesterol levels were significantly higher in CHD patients with the CAV-1 rs3807990-T allele than in patients with CC genotype (p=0.017). There was a statistically significant correlation between the rs3807990-T allele and hypercholesterolemia in the CHD group (p=0.008). The multivariate analysis confirmed that the CAV-1 rs3807990-T allele (p=0.011) is a risk factor for hypercholesterolemia. Moreover, the serum HDL-Cholesterol level was detected to be higher in patients carrying both CAV1-rs3807990-T and NOS3-rs1799983-T alleles than those with the CAV-1 rs3807990-CC/NOS3-rs1799983-GG genotype subgroup (p=0.013). These results suggested that the genetic variations of CAV-1 rs3807990 and NOS3-rs1799983 may contribute to the increased hypercholesterolemia risk and thus on the development of CHD.Cite this article as: İlikay S, Coşkunpınar E, Kurnaz-Gömleksiz Ö, Buğra Z, Eronat AP, Öztürk O, Yılmaz-Aydoğan H (2019). Effects of common variations of NOS3 and CAV1 genes on hypercholesterolemic profile in coronary heart disease. Istanbul J Pharm 49 (2): 53-60.

Keywords

Cav1 NOS3 gene hypercholesterolemia lipid CHD

🔖

Cite This Article

İLİKAY, S., COŞKUNPINAR, E., KURNAZ-GÖMLEKSİZ, Ö., BUĞRA, Z., ERONAT, A. P., ÖZTÜRK, O., YILMAZ-AYDOĞAN, H. (2019). Effects of common variations of NOS3 and CAV1 genes on hypercholesterolemic profile in coronary heart disease. İstanbul Journal of Pharmacy, Cilt: 49 - Sayı: 2, 53–60. https://ajindex.com/articles/41752

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, Looft-Wilson R, Murata T, Salomone S, Shin HK, Ayata C, Moskowitz MA, Michel T, Sessa WC, Huang PL (2007). The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 117: 1961-1967.
Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart EJ (1999). Oxidized low-density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274: 32512-32519.
Carey RM, Schoeffel CD, Gildea JJ, Jones JE, McGrath HE, Gordon LN, Park MJ, Sobota RS, Underwood PC, Williams J, Sun B, Raby B, Lasky-Su J, Hopkins PN, Adler GK, Williams SM, Jose PA, Felder RA (2012). Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension 60: 1359-1366.
Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109: 1359-1365.
Chen PF, Tsai AL, Berka V, Wu K (1996). Endothelial nitric-oxide synthase evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem 271: 14631-14635.
Chen S, Wang C, Wang X, Xu C, Wu M, Wang P, Tu X, Wang QK (2015). Significant Association between CAV1 Variant rs3807989 on 7p31 and Atrial Fibrillation in a Chinese Han Population. J Am Heart Assoc 4: e001980.
Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, Rossi G, Clerico A, Biagini A (2002). Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87: 525-528.
Conde MC, Ramirez-Lorca R, Lopez-Jamar JM, Molero E, Ramirez-Armengol JA, Moreno Nogueira JA, Pascual MH, Ruiz A, Martin-Cordova CG, Real LM, Royo JL (2006). Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep 16: 353-359.
Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP (1997). Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525-6533.
Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001). Loss o